FUTURE OF TUMOR IMMUNOLOGY

[61] EDYNAK EM, 1970, P AM ASSOC CANC RES, V11, P22

[62] Eilber F R, 1970, Cancer, V25, P362, DOI 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO

[63] 2-V

[64] EILBER FR, 1970, CANCER, V26, P588, DOI 10.1002/1097-0142(197009)26:3<588::AID-CNCR2820260314>3.0.CO

[65] 2-K

[66] EILBER FR, 1970, J NATL CANCER I, V44, P651

[67] EILBER FR, 1971, ANN INTERN MED, V74, P595

[68] FALK J, 1971, LANCET, V2, P1118

[69] FEFER A, 1969, CANCER RES, V29, P2177

[70] FINK MA, 1965, CANCER, V18, P1317, DOI 10.1002/1097-0142(196510)18:10<1317::AID-CNCR2820181018>3.0.CO

[61] EDYNAK EM, 1970, P AM ASSOC CANC RES, V11, P22

[62] Eilber F R, 1970, Cancer, V25, P362, DOI 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO

[63] 2-V

[64] EILBER FR, 1970, CANCER, V26, P588, DOI 10.1002/1097-0142(197009)26:3<588::AID-CNCR2820260314>3.0.CO

[65] 2-K

[66] EILBER FR, 1970, J NATL CANCER I, V44, P651

[67] EILBER FR, 1971, ANN INTERN MED, V74, P595

[68] FALK J, 1971, LANCET, V2, P1118

[69] FEFER A, 1969, CANCER RES, V29, P2177

[70] FINK MA, 1965, CANCER, V18, P1317, DOI 10.1002/1097-0142(196510)18:10<1317::AID-CNCR2820181018>3.0.CO